CARsgen Presents First-in-human Results of GPRC5D Targeting CAR-T CT071 at EHA 2024 By Investing.com Read more
JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89) Read more